meta_analysis
2023
High Quality
The optimal dose of oral tranexamic acid in melasma: A network meta-analysis
Feng X, Su H
Published in Indian Journal of Dermatology, Venereology and Leprology
Methodology
Network meta-analysis of randomized trials of oral tranexamic acid doses for melasma.
Key Findings
Oral tranexamic acid reduced melasma severity scores across doses, with lower doses performing comparably to higher ones.
Conclusions
Oral tranexamic acid is an effective prescription option for melasma; it is a drug, not a supplement.
Limitations
Heterogeneous concomitant therapies; thrombotic risk requires medical screening.
Outcomes Measured
Hyperpigmentation Reduction
Primary
The optimal dose of oral tranexamic acid in melasma: A network meta-analysis
Related Health Concerns
Study Details
Year:2023
Quality Score:8/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.